Luteal phase defects following agonist-triggered ovulation: a patient-dependent response

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.9, Iss.1, 2004-07, pp. : 22-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Luteal phase characteristics following GnRH antagonist or agonist treatment – a comparative study

By Friedler Shevach Gilboa Sarit Schachter Morey Raziel Arieh Strassburger Devorah Ron El Raphael

Reproductive BioMedicine Online, Vol. 12, Iss. 1, 2006-01 ,pp. : 27-32

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Treatment of Luteal Phase Defects in Assisted Reproduction

Current Drug Targets, Vol. 14, Iss. 8, 2013-07 ,pp. : 832-842

Bentham Science Publishers

Access to resources Recommend Favorite

Case Report: Achievement of pregnancy three times in the same patient during luteal GnRH agonist administration

By Papanikolaou Evangelos G Platteau Peter Albano Carola Kolibianakis Efstratios Devroey Paul

Reproductive BioMedicine Online, Vol. 10, Iss. 3, 2005-03 ,pp. : 347-349

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ Caglar GS Sozen E Akarsu C Tuncay G Ozbıcer T Vicdan K

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Luteal phase support

By Alam Veronica Vega Margarita Rísquez Francisco

Reproductive BioMedicine Online, Vol. 3, Iss. 3, 2001-11 ,pp. : 250-262

Reproductive Healthcare Ltd

Access to resources Recommend Favorite